Pyrrolidinedione derivatives as antibacterial agents with a novel mode of action.
暂无分享,去创建一个
Thomas Lampe | Christoph Freiberg | T. Lampe | N. Brunner | C. Freiberg | J. Pohlmann | J. Pernerstorfer | Peter G Nell | Jens Pohlmann | Mitsuyuki Shimada | Josef Pernerstorfer | Niels Svenstrup | Nina A Brunner | Guido Schiffer | M. Shimada | P. Nell | N. Svenstrup | G. Schiffer | Guido Schiffer
[1] G. Waldrop,et al. Overexpression and Kinetic Characterization of the Carboxyltransferase Component of Acetyl-CoA Carboxylase* , 1998, The Journal of Biological Chemistry.
[2] D. Dockery,et al. Effects of cigarette smoking on lung function in adolescent boys and girls. , 1996, The New England journal of medicine.
[3] A. Ricci,et al. Reactivity of N-phenacyloxycarbamates and related systems in the presence of bases: study of a new [1,2] anionic rearrangement , 1983 .
[4] Ashutosh Kumar Singh,et al. A convenient diastereoselective total synthesis of andrimid , 1991 .
[5] J. T. Magee,et al. Clinical significance of the emergence of bacterial resistance in the hospital environment , 2002, Journal of applied microbiology.
[6] K. Nakanishi,et al. Andrimid, a new peptide antibiotic produced by an intracellular bacterial symbiont isolated from a brown planthopper , 1987 .
[7] R. Moellering,et al. Antimicrobial-drug resistance. , 1996, The New England journal of medicine.
[8] R. Andersen,et al. Andrimid and moiramides A-C, metabolites produced in culture by a marine isolate of the bacterium Pseudomonas fluorescens: structure elucidation and biosynthesis , 1994 .
[9] D. Livermore. Bacterial resistance: origins, epidemiology, and impact. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[10] S. Davies,et al. Asymmetric syntheses of moiramide B and andrimid , 1998 .
[11] S. Davies,et al. Asymmetric synthesis of moiramide B , 1996 .
[12] Thomas Lampe,et al. Identification and Characterization of the First Class of Potent Bacterial Acetyl-CoA Carboxylase Inhibitors with Antibacterial Activity* , 2004, Journal of Biological Chemistry.
[13] R. Finch,et al. Bacterial resistance--the clinical challenge. , 2002, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[14] K. Nakanishi,et al. Stereocontrolled synthesis of andrimid and a structural requirement for the activity , 1989 .
[15] Y. Yamaoka,et al. Anti-bacillus substance in the marine sponge, Hyatella species, produced by an associated Vibrio species bacterium. , 1994, Microbios.